LET’S GET YOU MORE INFORMATION.

 

The information you provide will be used by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company, our affiliates, and our service providers to provide you information about Janssen products and additional services. Our Privacy Policy further governs the use of information you provide. By providing the information and selecting the SUBMIT button, you indicate that you have read, understand, and agree with these terms.

Tell us a few things about yourself, and we’ll handpick resources that we think will help support you the most along your PAH journey. It’ll just take a couple minutes.

*Required Information

I'm
This field is required
This field is required
 !
Hi  !
(This is where we’ll send you helpful PAH resources)
I’ve had PAH for
This field is required
 years.*
This is where I am in my PAH journey:
This field is required
When it comes to my PAH treatment, what matters most to me is:
Please rank the statements below – 1 being most important, 3 being least important.
Limiting side effects…even if that means my PAH progression is not being slowed down
Slowing down PAH progression…even if that means I may experience side effects
Feeling better today…even if that means my PAH progression is not being slowed down
Use 1, 2, and 3 only once
Optional
My next trip to the doctor is: (If we know when, we can pick some resources that may help you get ready)
DATE MUST NOT BE IN THE PAST
Optional
I'd also like to be contacted about additional information by:

REQUIRED FOR TEXT MESSAGES

By providing my phone number, I consent to receiving support, reminder, and educational text messages from Actelion to my mobile phone number. Standard text messaging rates will apply.

REQUIRED FOR MAIL
REQUIRED FOR MAIL
REQUIRED FOR MAIL
REQUIRED FOR MAIL

This field is required

The information you provide will be used by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company, our affiliates, and our service providers to provide you information about Janssen products and additional services. Our Privacy Policy further governs the use of information you provide. By providing the information and selecting the SUBMIT button, you indicate that you have read, understand, and agree with these terms.

Question 1 of 7
LET’S GET YOU MORE INFORMATION.
 

Please fill out the form below to receive helpful information on UPTRAVI® (selexipag) and resources related to delaying PAH progression.

Tell us a few things about yourself, and we’ll handpick resources that we think will help support you the most along your PAH journey. It’ll just take a couple minutes.

*Required information

This field is required
First Name*
This field is required
Last Name*
This field is required
This field is required

The information you provide will be used by Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company, our affiliates, and our service providers to provide you information about Janssen products and additional services. Our Privacy Policy further governs the use of information you provide. By providing the information and selecting the SUBMIT button, you indicate that you have read, understand, and agree with these terms.

thank you
 
Look for information in your inbox about PAH and ways to talk to your doctor about disease progression.
Learn more about living with PAH
IMPORTANT SAFETY INFORMATION
EXPAND +
What are the possible side effects of UPTRAVI®?

The most common side effects are:

  • Headache
  • Diarrhea
  • Jaw pain
  • Nausea
  • Muscle pain
  • Vomiting
  • Pain, redness or swelling at the injection site with UPTRAVI® for injection
  • Pain in arms or legs
  • Temporary reddening of the skin (flushing)
  • Joint pain
  • Low red blood cell count
  • Less appetite than usual
  • Rash

Talk to your doctor if you have a side effect that bothers you or does not go away. These are not all the possible side effects of UPTRAVI®. For more information, ask your doctor or pharmacist.

You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Keep UPTRAVI® and all other medicines away from children.

What other medicines might interact with UPTRAVI®?

UPTRAVI® and other medicines may affect each other, causing side effects. Tell your doctor about all the medicines you are taking. Do not start any new medicine until you check with your doctor.

How should I take UPTRAVI®?
UPTRAVI® Tablets
  • Take UPTRAVI® exactly as your doctor tells you to take it. Usually, your doctor will have you take UPTRAVI® twice a day. Taking UPTRAVI® with food may help you tolerate UPTRAVI® better
  • Swallow UPTRAVI® tablets whole. Do not split, crush, or chew tablets
  • Tell your doctor if you have any form of liver disease. Your doctor may need to change your dose of UPTRAVI®
  • UPTRAVI® is measured in micrograms (mcg). Tablets come in the following strengths: 200, 400, 600, 800, 1000, 1200, 1400, and 1600 mcg
UPTRAVI® given by intravenous (IV) injection
  • Your healthcare provider will give you UPTRAVI® into your vein through an intravenous (IV) line
  • Your healthcare provider will decide how much UPTRAVI® for injection you will receive each day based on your current dose of UPTRAVI® tablets
What is UPTRAVI®?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs.

UPTRAVI® can help delay (slow down) the progression of your disease and lower your risk of being hospitalized for PAH.

It is not known if UPTRAVI® is safe and effective in children.

Please see full Prescribing Information and Patient Product Information.

cp-113991v5

+
IMPORTANT SAFETY INFORMATION
+
What is UPTRAVI®?
IMPORTANT SAFETY INFORMATION
What are the possible side effects of UPTRAVI®?

The most common side effects are:

  • Headache
  • Diarrhea
  • Jaw pain
  • Nausea
  • Muscle pain
  • Vomiting
  • Pain, redness or swelling at the injection site with UPTRAVI® for injection
  • Pain in arms or legs
  • Temporary reddening of the skin (flushing)
  • Joint pain
  • Low red blood cell count
  • Less appetite than usual
  • Rash

Talk to your doctor if you have a side effect that bothers you or does not go away. These are not all the possible side effects of UPTRAVI®. For more information, ask your doctor or pharmacist.

You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Keep UPTRAVI® and all other medicines away from children.

What other medicines might interact with UPTRAVI®?

UPTRAVI® and other medicines may affect each other, causing side effects. Tell your doctor about all the medicines you are taking. Do not start any new medicine until you check with your doctor.

How should I take UPTRAVI®?
UPTRAVI® Tablets
  • Take UPTRAVI® exactly as your doctor tells you to take it. Usually, your doctor will have you take UPTRAVI® twice a day. Taking UPTRAVI® with food may help you tolerate UPTRAVI® better
  • Swallow UPTRAVI® tablets whole. Do not split, crush, or chew tablets
  • Tell your doctor if you have any form of liver disease. Your doctor may need to change your dose of UPTRAVI®
  • UPTRAVI® is measured in micrograms (mcg). Tablets come in the following strengths: 200, 400, 600, 800, 1000, 1200, 1400, and 1600 mcg
UPTRAVI® given by intravenous (IV) injection
  • Your healthcare provider will give you UPTRAVI® into your vein through an intravenous (IV) line
  • Your healthcare provider will decide how much UPTRAVI® for injection you will receive each day based on your current dose of UPTRAVI® tablets
What is UPTRAVI®?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs.

UPTRAVI® can help delay (slow down) the progression of your disease and lower your risk of being hospitalized for PAH.

It is not known if UPTRAVI® is safe and effective in children.

Please see full Prescribing Information and Patient Product Information.

cp-113991v5

×